<!DOCTYPE HTML>
<!--
	TXT by HTML5 UP
	html5up.net | @ajlkn
	Free for personal and commercial use under the CCA 3.0 license (html5up.net/license)
-->
<html>
	<head>
		<title>No Sidebar - TXT by HTML5 UP</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1" />
		<!--[if lte IE 8]><script src="assets/js/ie/html5shiv.js"></script><![endif]-->
		<link rel="stylesheet" href="assets/css/main.css" />
		<!--[if lte IE 8]><link rel="stylesheet" href="assets/css/ie8.css" /><![endif]-->
	</head>
	<body>
		<div id="page-wrapper">

			<!-- Header -->
				<header id="header">
					<div class="logo container">
						<div>
							<h1><a href="index.html" id="logo">TXT</a></h1>
							<p>A responsive site template by HTML5 UP</p>
						</div>
					</div>
				</header>

			<!-- Nav -->
				<nav id="nav">
					<ul>
						<li><a href="index.html">Home</a></li>
						<li>
							<a href="#">Dropdown</a>
							<ul>
								<li><a href="#">Lorem ipsum dolor</a></li>
								<li><a href="#">Magna phasellus</a></li>
								<li>
									<a href="#">Phasellus consequat</a>
									<ul>
										<li><a href="#">Lorem ipsum dolor</a></li>
										<li><a href="#">Phasellus consequat</a></li>
										<li><a href="#">Magna phasellus</a></li>
										<li><a href="#">Etiam dolore nisl</a></li>
									</ul>
								</li>
								<li><a href="#">Veroeros feugiat</a></li>
							</ul>
						</li>
						<li><a href="left-sidebar.html">Left Sidebar</a></li>
						<li><a href="right-sidebar.html">Right Sidebar</a></li>
						<li class="current"><a href="no-sidebar.html">No Sidebar</a></li>
					</ul>
				</nav>

			<!-- Main -->
				<div id="main-wrapper">
					<div id="main" class="container">
						<div class="row">
							<div class="12u">
								<div class="content">

									<!-- Content -->

										<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta http-equiv="content-type" content="text/html;charset=utf-8"/>
		<title>Monday.html</title>
		<style type="text/css" media="screen"><!--
			tbody, thead, tfoot, tr, td, th {
				border-style : inherit;
				border-width : inherit;
				border-color : inherit;
			}
			td {
				width : 10px;
				height : 5px;
			}
			.leftFloat {
				float : left;
			}
			.rightFloat {
				float : right;
			}
			span.char-style-override-1 {
				font-family : 'Open Sans', sans-serif;
				font-weight : 300;
				letter-spacing: 12px;
				font-style : normal;
				padding-bottom: 15px;
				font-size : 2.5em;
				color : #045292;
			}
			span.char-style-override-2 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.5em;
				font-style : normal;
				font-weight : 300;
			}
			span.char-style-override-3 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.5em;
				font-style : normal;
				font-weight : 600;
			}
			span.char-style-override-4 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.3em;
				font-style : normal;
				font-weight : 600;
			}
			span.char-style-override-5 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.3em;
				font-style : normal;
				font-weight : 300;
			}
			span.char-style-override-6 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.3em;
				font-style : normal;
				font-weight : 300;
			}
			span.char-style-override-7 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.3em;
				font-style : normal;
				font-weight : 300;
				text-transform : uppercase;
			}
				span.char-style-override-8 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1em;
				font-style : normal;
				font-weight : 300;
			}
			p.No-Paragraph-Style {
				font-family : "Minion Pro", serif;
				font-weight : normal;
				font-style : normal;
				font-size : 1em;
				text-decoration : none;
				font-variant : normal;
				line-height : 1.2;
				text-align : left;
				color : #000000;
				text-indent : 0px;
				margin : 0px;
			}
			p.para-style-override-1 {
				margin-top : 30px;
				padding-top: 12px;
				border-top : 2px solid #045292;
				text-align: justify;
			}
			p.para-style-override-2 {
				margin-top : 9px;
				color: #045292;
			}
			p.para-style-override-3 {
				margin-left: 58px;
				margin-top : 6px;
			}
			p.para-style-override-4 {
				margin-left : 55px;
				margin-right : 0px;
				margin-top : 20px;
				text-indent : -55px;
			}
			p.para-style-override-5 {
				margin-left : 55px;
				margin-top : 3px;
			}
			p.para-style-override-6 {
				margin-left : 55px;
				margin-top : 3px;
			}
			div.Basic-Text-Frame  {
			  margin-left : 28px;
			  margin-right: 20px;
			}
{
			}
		--></style>
	</head>
	</head>
	<body>
		<div id="Monday.html" xml:lang="en-US">
			<div class="Basic-Text-Frame">
				<p class="No-Paragraph-Style"><span class="char-style-override-1">Monday, July 4, 2016</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">8:00 - 9:00&emsp;&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">PLENARY SESSION: HEALTH PRIORITIES FOR THE FUTURE</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">W. Fokkens </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span><span class="char-style-override-5">21</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">8:00	HEALTH STATUS IN THE WORLD TODAY22</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H. Nordenstedt </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">8:30	FUTURE CHALLENGES IN RHINOLOGY23</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">P.&nbsp;Stjärne</span><span class="char-style-override-5"> (Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 1: THE EASY AND COMPLICATED FRONTAL SINUS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">P. Stjärne </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">24</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	ANATOMY25</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A. Leunig </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	WHEN AND WHY?26</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D. Simmen </span><span class="char-style-override-5">(Switzerland)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:47	HOW?27</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.J. Wormald </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:06	WHICH WAY?28</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H. Gassner </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 2: HOW TO SUCCEED IN SEPTAL CORRECTION</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">C. von Buchwald </span><span class="char-style-override-5">(Denmark)</span><span class="char-style-override-4"></span><span class="char-style-override-5">29</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	INVESTIGATION &amp; INDICATIONS30</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">B. Alinasab </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	SWEDISH AUDIT31</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">C.&nbsp;Ahlström Emanuelsson</span><span class="char-style-override-5"> (Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:47	EXTRACORPORAL AND OPEN APPROACH TO THE SEPTUM32</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">A.&nbsp;Rabie</span><span class="char-style-override-5"> (Egypt)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:06	ENDOSCOPIC TECHNIQUE33</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Haruna</span><span class="char-style-override-5"> (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 3: MANAGEMENT OF OLFACTORY LOSS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">M. Bende </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">34</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	OVERVIEW &amp; PREDICTORS OF THERAPEUTIC OUTCOME35</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">B. Landis </span><span class="char-style-override-5">(Switzerland)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	OLFACTORY TRAINING36</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">T.&nbsp;Hummel </span><span class="char-style-override-5">(Germany)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:47	TOPICAL THERAPIES37</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">T.&nbsp;Miwa</span><span class="char-style-override-5"> (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:06	SURGICAL TREATMENT OF OLFACTORY LOSS38</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.&nbsp;Hedén Blomqvist</span><span class="char-style-override-5"> (Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 4: NASAL OBSTRUCTION IN CHILDREN</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">H. Moriyama </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span><span class="char-style-override-5">39</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	CHOANAL ATRESIA 40</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Dahm </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	WHEN AND HOW TO OPERATE SEPTAL DEVIATION IN CHILDREN41</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">I. Tasca </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:47	DIFFERENTIAL DIAGNOSIS: ALLERGY, ADENOIDS OR CRS42</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">F.&nbsp;Baroody</span><span class="char-style-override-5"> (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:06	NASAL POLYPS IN CHILDREN43</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Cornet </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 5: JUNIOR MEMBER SYMPOSIUM: “RHINOLOGY”</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">C. Rennie </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-5">44</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	INTRODUCTORY TALK45</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">V. Lund </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	INSTRUCTIONAL LECTURE 46</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C. Hopkins </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:46	ANTI-ALLERGIC EFFECTS OF ANTI-IL-33 IS ASSOCIATED WITH SUPPRESSION OF IMMUNOGLOBULIN LIGHT CHAIN AND INDUCIBLE NITRIC OXIDE SYNTHASE47</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">T.Y.&nbsp;Jang, C.S.&nbsp;Park, A.Y.&nbsp;Jung, </span><span class="char-style-override-4">Y.H.&nbsp;Kim</span><span class="char-style-override-5"> (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:53	DUPILUMAB REDUCES LOCAL TYPE 2 PROINFLAMMATORY BIOMARKERS IN PATIENTS WITH CHRONIC SINUSITIS AND NASAL POLYPOSIS48</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Jonstam</span><span class="char-style-override-5">, G.&nbsp;Holtappels, B.&nbsp;Swanson, L.&nbsp;Mannent, L.O.&nbsp;Cardell, N.&nbsp;Tian, Y.&nbsp;Wang, D.&nbsp;Zhang, C.&nbsp;Fan, J.&nbsp;Hamilton, A.&nbsp;Grabher, G.&nbsp;Pirozzi, C.&nbsp;Bachert (Sweden)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:00	A RANDOMISED CONTROLLED TRIAL OF SODIUM CITRATE SPRAY FOR NON-CONDUCTIVE OLFACTORY DISORDERS49</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">C.&nbsp;Philpott, </span><span class="char-style-override-4">S.&nbsp;Erskine</span><span class="char-style-override-5">, A.&nbsp;Clark, A.&nbsp;Leeper, R.&nbsp;Sharma, S.&nbsp;Patel, G.&nbsp;Murty (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:07	CASES - PANEL DISCUSSION	</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall F</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 6: PRECISION MEDICINE IN RHINOLOGY DISEASES</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">T. Smith </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-5">50</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	ALLERGIC RHINITIS51</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L. Klimek </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	NON-ALLERGIC RHINITIS52</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Hellings </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:47	CRSsNP53</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A. Cervin </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:06	CRSwNP54</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">C.&nbsp;Bachert</span><span class="char-style-override-5"> (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 7: THE INNATE IMMUNE SYSTEM IN CRS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">V. Kozlov </span><span class="char-style-override-5">(Russia)</span><span class="char-style-override-4"></span><span class="char-style-override-5">55</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	THE ROLE OF ANTIMICROBIAL PEPTIDES IN THE NOSE56</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Carney </span><span class="char-style-override-5">(Australia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	THE IMPACT OF INNATE IMMUNITY IN CRS57</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A. Lane </span><span class="char-style-override-5">(France)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:47	TARGETING THE INNATE IMMUNE SYSTEM FOR TREATMENT58</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">N.&nbsp;Cohen</span><span class="char-style-override-5"> (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:06	ROLE OF EPITHELIAL CELLS AND ILC’S IN INNATE IMMUNITY59</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K. van Drunen </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 1: DIAGNOSIS OF CHRONIC RHINOSINUSITIS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">W. Bolger </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-5">60</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	MEDICATION USE BETWEEN CHRONIC RHINOSINUSITIS SUBTYPES: DATA FROM THE CHRONIC RHINOSINUSITIS EPIDEMIOLOGICAL STUDY (CRES)PRESENTED ON BEHALF OF THE CRES GROUP61</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Erskine</span><span class="char-style-override-5">, A.&nbsp;Clark, C.&nbsp;Philpott,  The CRES Group (United Kingdom)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:22	CHARACTERIZATION OF CT-SCAN HYPERDENSITIES IN FUNGUS BALL OF THE PARANASAL SINUSES: PRELIMINARY RESULTS62</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">N.&nbsp;Réville, S.&nbsp;Molinier, L.&nbsp;De Gabory, </span><span class="char-style-override-4">P.L.&nbsp;Bastier</span><span class="char-style-override-5"> (France)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:34	NASAL AND SINUS SYMPTOMS IN CHRONIC RHINOSINUSITIS AND NASAL ALLERGY; IMAGING OF THE NASAL SINUS IN THE NORMAL POPULATION63</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D.&nbsp;Dietz de Loos</span><span class="char-style-override-5">, M.&nbsp;Wildeman, N.J.M.&nbsp;Freling, W.J.&nbsp;Fokkens (Netherlands)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:46	NASAL NITRIC OXIDE MEASUREMENT IN MANAGEMENT OF CHRONIC RHINOSINUSITIS64</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">L.&nbsp;Jovancevic</span><span class="char-style-override-5">, S.&nbsp;Savovic (Serbia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:58	THE IMPORTANCE OF ENT EVALUATION IN PERSONS WITH NSAID INTOLERANCE65</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">B.&nbsp;Lange</span><span class="char-style-override-5">, A.&nbsp;D Kjeldsen, C.&nbsp;G Mortz, C.&nbsp;Bindslev-Jensen (Denmark)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:10	EOSINOPHIL FUNGAL RHINOSINUSITIS: A SEPARATE CLINICAL ENTITY ?66</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Vlaminck</span><span class="char-style-override-5">, K.&nbsp;Speleman (Belgium)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 2: RHINOSINUSITIS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">J. Bretschneider </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span><span class="char-style-override-5">67</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	DISCRIMINATION BETWEEN RHINOSINUSITIS AND RHINITIS IN ASTHMA USING LOSS OF SMELL AS A SYMPTOM-GUIDE68</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;José A</span><span class="char-style-override-5">., P.&nbsp;César, P.&nbsp;Vicente, R.&nbsp;Gustavo, J.&nbsp;Berta, M.&nbsp;Joaquim (Spain)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:19	MORPHOLOGICAL CONCORDANCE BETWEEN CBCT AND MDCT: PRELIMINARY RESULTS69</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">G.&nbsp;De Bonnecaze</span><span class="char-style-override-5">, J.&nbsp;Demeslay, E.&nbsp;Mouchon, P.&nbsp;Cantet, S.&nbsp;Vergez, E.&nbsp;Serrano (France)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	IMPLICATING PATIENTS IN SINUS CARE: THE CHRONIC SINUSITIS ACTION PLAN (CSAP)70</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Nayan</span><span class="char-style-override-5">, S.&nbsp;Kilty, D.&nbsp;Sommer, M.&nbsp;Tewfik, E.&nbsp;Wright, B.&nbsp;Rotenberg, I.&nbsp;Witterick, M.&nbsp;Desrosiers (Canada)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:37	PUBLIC OUTREACH IN CRS: THE CANADIAN RHINOSINUSITIS WORKING GROUP INITIATIVE71</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Nayan</span><span class="char-style-override-5">, H.&nbsp;Lloyd, S.&nbsp;Kilty, P.&nbsp;Keith, M.&nbsp;Tewfik, M.&nbsp;Desrosiers (Canada)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:46	THE RELATIONSHIPS OF RHINOENDOSCOPY, CRP LEVELS AND POSITIVE CULTURE WITH QUALITY OF LIFE IN ACUTE RHINOSINUSITIS72</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Schalek</span><span class="char-style-override-5">, Z.&nbsp;Hornackova, L.&nbsp;Hart (Czech Republic)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:55	ENDOSCOPIC SURGERY FOR THE TREATMENT OF ACUTE INVASIVE FUNGAL SINUSITIS IN HAEMATOLOGICAL PATIENTS: ANALYSIS OF 16 PATIENTS.73</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">V.&nbsp;Sciarretta</span><span class="char-style-override-5">, I.J.&nbsp;Fernandez, P.&nbsp;Farneti, M.C.&nbsp;Cimatti, C.&nbsp;Francesco, M.&nbsp;Stanzani, E.&nbsp;Pasquini (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:04	THE BURDEN AND MANAGEMENT OF RHINITIS AND RHINOSINUSITIS  IN PRIMARY CARE74</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">W.&nbsp;Fokkens</span><span class="char-style-override-5">, A.&nbsp;Nibber, A.&nbsp;Chisholm, P.&nbsp;Hellings, D.&nbsp;Nibber, D.&nbsp;Price (Netherlands)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 3: MANAGEMENT OF CRS SURGICALLY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">M. Benninger </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-5">75</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	SINUS SURGERY POSTPONES CHRONIC GRAM-NEGATIVE LUNG INFECTION: COHORT STUDY OF 106 PATIENTS WITH CYSTIC FIBROSIS76</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">M.&nbsp;Alanin</span><span class="char-style-override-5">, K.&nbsp;Aanaes, N.&nbsp;Høiby, P.&nbsp;Tania, S.&nbsp;Marianne, K.G.&nbsp;Nielsen, D.&nbsp;Taylor-Robinseon, E.&nbsp;Waldmann, C.&nbsp;Von Buchwald (Denmark)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:22	THE PRESENCE OF EOSINOPHILIC MUCIN AND FUNGAL HYPHAE INFLUENCES THE SURGICAL OUTCOME IN NASAL POLYP PATIENTS77</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Vlaminck</span><span class="char-style-override-5">, K.&nbsp;Speleman, E.&nbsp;Prokopakis, H.&nbsp;Kawauchi, P.&nbsp;Hellings, M.&nbsp;Jorissen, F.&nbsp;Acke, C.&nbsp;Bachert, P.&nbsp;Gevaert (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:34	FUNGUS BALL OF THE PARANASAL SINUS: A 15 YEAR EXPERIENCE OF A TERTIARY BELGIAN CENTER78</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Eloy</span><span class="char-style-override-5">, M.&nbsp;Caroline (Belgium)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:46	SYSTEMATIC REVIEW OF PATIENT REPORTED OUTCOMES FOR REVISION ENDOSCOPIC SINUS SURGERY79</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">E.&nbsp;Fong, S.&nbsp;Prasad, </span><span class="char-style-override-4">E.&nbsp;Ooi</span><span class="char-style-override-5">, C.&nbsp;Woods (Australia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:58	FISTULA RATE ATTRIBUTABLE TO MINI-TREPHINATION IN PATIENTS WITH FRONTAL SINUS DISEASE: OUR 5 YEAR EXPERIENCE80</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">R.&nbsp;Hettige</span><span class="char-style-override-5">, R.&nbsp;Almeyda, P.&nbsp;Martinez-Devesa (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:10	ENDOSCOPIC ENDONASAL MANAGEMENT OF RECURRENT MAXILLARY MUCOCELES USING BILIARY T-TUBE STENTING81</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Ikeda</span><span class="char-style-override-5">, S.&nbsp;Ito, N.&nbsp;Ono (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">10:25 - 11:00Exhibition</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">COFFEE BREAK, EXHIBITION AND POSTER VIEWING</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 8: HOW TO ACCESS ANTERIOR SKULL BASE LESIONS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">C. Ahlström Emanuelsson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">82</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	ENDOSCOPIC APPROACHES TO THE ANTERIOR SKULL BASE83</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">I.&nbsp;Alobid </span><span class="char-style-override-5">(Spain)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	SKULL BASE TUMOR SURGERY84</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H.R.&nbsp;Briner</span><span class="char-style-override-5"> (Switzerland)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:36	CHALLENGING CASES85</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Carrau </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:54	FUTURE POSSIBILITIES86</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Castelnuovo </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 9: THE CHALLENGES OF FACIAL PLASTIC SURGERY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">P. Palma </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span><span class="char-style-override-5">87</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">P. Hellings </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span><span class="char-style-override-5">88</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	CHALLENGES: PAEDIATRIC RHINOPLASTY89</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Andrews</span><span class="char-style-override-5"> (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	BRIDGING THE GAP BETWEEN FORM AND FUNCTION90</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.J.&nbsp;Tasman</span><span class="char-style-override-5"> (Switzerland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:37	TEACHING FACE LIFT SURGERY 91</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H. Gassner </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:56	RECONSTRUCTING THE NOSE92</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.O. Wikström </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 10: THE NOSE AND OSA</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">A. Törngren </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">93</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	ALGORITHM FOR WORKUP OF OSA PATIENTS94</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S. Berg </span><span class="char-style-override-5">(Denmark)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:15	CAN NASAL TREATMENT EFFECT OSA95</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Bhik</span><span class="char-style-override-5"> (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:30	NASAL COMPLAINTS IN PATIENTS WITH OSA96</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J.&nbsp;Hellgren</span><span class="char-style-override-5"> (Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:45	NASAL CONGESTION AND SNORING97</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K. Naito </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:00	NEW TREATMENT OPTIONS98</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Gerek </span><span class="char-style-override-5">(Turkey)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 11: THE RHINOLOGIC CHALLENGES OF CYSTIC FIBROSIS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">Z. Soler </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-5">99</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	CHARACTERISTICS OF THE CF AND PCD PATIENTS100</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Berkhout </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	THE SINONASAL IMPACT IN CYSTIC FIBROSIS101</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Jorissen </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:37	WHEN TO PERFORM SURGERY102</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Aanaes</span><span class="char-style-override-4"></span><span class="char-style-override-5"> (Denmark)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:56	TREATMENT - STATE OF THE ART103</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S. Carrie </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 12: JUNIOR MEMBER SYMPOSIUM: NOT ONLY FOR JUNIORS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">J. Pimentel </span><span class="char-style-override-5">(Portugal)</span><span class="char-style-override-4"></span><span class="char-style-override-5">104</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	HOW TO WRITE A PAPER105</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">W. Fokkens </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:12	FELLOWSHIPS: WHAT ARE YOUR OPTIONS? 106</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Surda </span><span class="char-style-override-5">(Slovakia)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:25	FELLOWSHIPS: WHAT ARE YOUR OPTIONS?107</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">A.L.&nbsp;Poirrier</span><span class="char-style-override-5">, P.&nbsp;Surda (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:37	HOW TO FUND YOUR RESEARCH108</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Hellings </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:50	RECENT ADVANCES IN RHINOLOGY AND TRAINING109</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.V.&nbsp;Tomazic</span><span class="char-style-override-5">, J.&nbsp;Pimentel (Austria)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:02	COLLABORATIONS WITH EAACI110</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.V.&nbsp;Tomazic</span><span class="char-style-override-5">, O.&nbsp;Tsilochristou (Austria)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall F</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 13: DIAGNOSIS AND TREATMENT IN ORBITAL DISEASES</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">S. Haruna </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span><span class="char-style-override-5">111</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	IMPLODING AND EXPLODING SINUSES112</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">V. Lund </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:15	DCR113</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K. Steensland </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:30	LACRIMAL TUMOURS114</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Eloy </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:45	ORBITAL TUMOURS115</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">I. Dallan </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:00	ORBITAL DECOMPRESSION116</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Sahlstrand-Johnson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 14: FROM BENCH TO BEDSIDE IN RHINOLOGY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">L. Cardell </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">117</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	FROM CYTOKINES TO ENDOTYPES IN CRS- GALEN ANSWERS?118</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Gevaert </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	NEW DRUGS FOR OLD - ARE MONOCLONAL ANTIBODIES THE ANSWER?119</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;Bachert</span><span class="char-style-override-5"> (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:37	TASTE RECEPTORS AND CRS120</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">N.&nbsp;Cohen</span><span class="char-style-override-5"> (USA)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:56	NEW DEVELOPMENTS IN IMMUNOTHERAPY121</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Moesges </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 4: MANAGEMENT OF CRS SURGICALLY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">A. Cervin </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span><span class="char-style-override-5">122</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	THE ROLE OF ANATOMICAL VARIATIONS (AV) IN THE DEVELOPMENT AND CURE OF CHRONIC RHINOSINUSITIS: A PROSPECTIVE STUDY123</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H.&nbsp;Abdel-Fattah</span><span class="char-style-override-5">, Z.&nbsp;Mandour, P.&nbsp;Eloy (Egypt)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:10	SURGIGAL TREATMENT OF CHRONIC MAXILLARY OSTEOMYELITIS USING BIOACTIVE GLASS S53P4.124</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">G.&nbsp;Bachmann-Harildstad</span><span class="char-style-override-5">, T.&nbsp;Olafsson (Norway)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:20	ENDOSCOPIC MANAGEMENT OF IATROGENIC FRONTAL SINUSITIS DUE TO FOREIGN BODY: BONE WAX SHOULD NOT BE USED FOR FRONTAL OBLITERATION125</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H.&nbsp;Basak</span><span class="char-style-override-5">, I.&nbsp;Yorulmaz, S.&nbsp;Beton, S.&nbsp;Mulazimoglu, H.&nbsp;Guliyev, B.&nbsp;Kucuk, C.&nbsp;Meco (Turkey)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:30	TARGET GUIDED SURGERY  (TGS) - INSTRUMENT GUIDANCE WITH BUILDING BLOCKS PLANNING AND AUGMENTED REALITY NAVIGATION IN SINUS SURGERY: AN EXPERIENCE REPORT126</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">O.&nbsp;Kaschke</span><span class="char-style-override-5">, B.&nbsp;Kosmecki, C.&nbsp;Winne (Germany)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:40	ENDOSCOPIC MAXILLARY MIDDLE  MEATAL ANTROSTOMY WITH ADDITIONAL APPROACH THROUGH  THE INFERIOR MEATUS127</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">V.&nbsp;Shkorbotun, </span><span class="char-style-override-4">T.&nbsp;Kunakh</span><span class="char-style-override-5">, Y.&nbsp;Shkorbotun (Ukraine)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:50	MODIFIED ENDOSCOPIC LOTHROP PROCEDURE IN TREATMENT OF CHRONIC FRONTAL SINUSITIS: A REPORT OF 60 CASES128</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Mickielewicz</span><span class="char-style-override-5">, I.&nbsp;Gwizdalska, E.&nbsp;Witkowska, A.&nbsp;Stepien, H.&nbsp;Skarzynski (Poland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:00	TRANSORBITAL ENDOSCOPIC MANAGEMENT OF SUPRAORBITAL ETHMOIDAL MUCOCELES: A NOVEL APPROACH129</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Naraghi</span><span class="char-style-override-5">, M.&nbsp;Afarideh (Iran)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 5: PATHOPHYSIOLOGY OF CRS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">G. Bachmann-Harildstad </span><span class="char-style-override-5">(Norway)</span><span class="char-style-override-4"></span><span class="char-style-override-5">130</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	MICROARRAY ANALYSIS OF EPITHELIAL AND FIBROBLAST CELLS IN CHRONIC RHINOSINUSITIS131</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Ball</span><span class="char-style-override-5">, D.&nbsp;Mann, A.&nbsp;Fisher, J.&nbsp;Wilson (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:12	ACTIVATION STATE OF CIRCULATING EOSINOPHILS IN NASAL POLYPOSIS132</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">V.&nbsp;Dupuch</span><span class="char-style-override-5">, A.&nbsp;Tridon, S.&nbsp;Ughetto, S.&nbsp;Walrand, K.&nbsp;Messaouidi, C.&nbsp;Dubray, A.&nbsp;Virlogeux, M.P.&nbsp;Vasson, N.&nbsp;Saroul, T.&nbsp;Mom, B.&nbsp;Evrard, L.&nbsp;Gilain (France)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:24	COULD SYSTEMIC INFLAMMATION MEDIATE THE PROPAGATION OF INFLAMMATION BETWEEN AIRWAY SEGMENTS IN CHRONIC RHINOSINUSITIS WITH NASAL POYPS AND ASTHMA?133</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Håkansson</span><span class="char-style-override-5">, A.E.&nbsp;Pedersen, B.&nbsp;Claus, K.&nbsp;Lars, T.&nbsp;Simon Francis, V.&nbsp;Backer, C.&nbsp;Von Buchwald (Denmark)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:36	CHRONIC PM2.5 EXPOSURE IS ASSOCIATED WITH TH2 MEDIATED EOSINOPHILIC SINONASAL INFLAMMATION134</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">A.&nbsp;Tharakan, X.&nbsp;Rao, T.&nbsp;Sussan, S.&nbsp;Lin, E.&nbsp;Toskala, S.&nbsp;Rajagopalan, </span><span class="char-style-override-4">M.&nbsp;Ramanathan </span><span class="char-style-override-5">Jr (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:48	DIVERSITY OF T-HELPER CYTOKINE-PROFILES IN CHRONIC RHINOSINUSITIS: A MULTICENTER STUDY IN EUROPE, ASIA AND OCEANIA135</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">X.&nbsp;Wang</span><span class="char-style-override-5">, N.&nbsp;Zhang, L.&nbsp;Zhang, C.&nbsp;Bachert (China)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:00	BACTERIAL BIOFILMS IN CHRONIC RHINOSINUSITIS; DISTRIBUTION AND PREVALENCE136</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">K.A.&nbsp;Danielsen, Ø.&nbsp;Eskeland, K.&nbsp;Fridrich, V.C.&nbsp;Orszagh, </span><span class="char-style-override-4">G.&nbsp;Bachmann-Harildstad</span><span class="char-style-override-5">, E.&nbsp;Burum-Auensen (Norway)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 6: PATHOPHYSIOLOGY OF CRS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">M. Bende </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">137</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	IMPACT OF MUCUS STASIS ON MICROBIOME AND TRANS-EPITHELIAL CHLORIDE TRANSPORT IN A PRECLINICAL MODEL OF RHINOSINUSITIS138</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">D.Y.&nbsp;</span><span class="char-style-override-4">Cho</span><span class="char-style-override-5">, B.&nbsp;Woodworth, D.&nbsp;Skinner, S.&nbsp;Zhang (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:10	SMOKING IN CRS: DATA FROM THE CHRONIC RHINOSINSUSITIS EPIDEMIOLOGY STUDY (CRES) 139</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Erskine</span><span class="char-style-override-5">, C.&nbsp;Hopkins, C.&nbsp;Philpott,  The CRES Group (United Kingdom)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:20	MECHANISMS OF STAPHYLOCOCCUS AUREUS INTERNALISATION WITHIN MAST CELLS AND ITS RELEVANCE TO THE PATHOGENESIS OF NASAL POLYPS.140</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Hayes</span><span class="char-style-override-5">, S.&nbsp;Pender, P.&nbsp;Harries, R.&nbsp;Salib (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:30	CROSS-TALK BETWEEN HUMAN MAST CELLS AND EPITHELIAL CELLS BY IGE-MEDIATED PERIOSTIN PRODUCTION IN EOSINOPHILIC NASAL POLYPS141</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D.K.&nbsp;Kim</span><span class="char-style-override-5">, D.W.&nbsp;Kim, H.R.&nbsp;Jin, S.H.&nbsp;Cho (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:40	SEMA4A CONTRIBUTES PHENOTYPES IN EOSINOPHILIC CHRONIC RHINOSINUSITIS (ECRS)142</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">Y.&nbsp;Maeda</span><span class="char-style-override-5">, S.&nbsp;Koyama, Y.&nbsp;Takeda, M.&nbsp;Hayama, T.&nbsp;Shikina, K.&nbsp;Takeda, S.&nbsp;Okazaki, T.&nbsp;Tsuda, A.&nbsp;Kumanogoh, H.&nbsp;Inohara (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:50	EFFECT OF STAPHYLOCOCCAL PROTEIN A-FORMULATED IMMUNE COMPLEXES ON EXOTOXIN-INDUCED CELLULAR RESPONSES IN NASAL POLYPS: ROLE OF SERUM.143</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Okano</span><span class="char-style-override-5">, T.&nbsp;Haruna, Y.&nbsp;Noyama, S.I.&nbsp;Makihira, K.&nbsp;Kanai, R.&nbsp;Fujiwara, R.&nbsp;Omichi, Y.&nbsp;Komatsubara, Y.&nbsp;Yamashita, K.&nbsp;Nishizaki (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:00	THE RELATIONSHIP BETWEEN SERUM VITAMIN D AND CHRONIC RHINOSINUSITIS: A SYSTEMATIC REVIEW144</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Stokes</span><span class="char-style-override-5">, J.&nbsp;Rimmer (Australia)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">12:15 - 14:15Exhibition</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">BREAK, EXHIBITION AND POSTER VIEWING</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">12:30 - 14:00&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INDUSTRY SUPPORTED SESSION</span></p>
				<p class="No-Paragraph-Style para-style-override-5"><span class="char-style-override-7">Session not included in the CME/CPD Programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-5"><span class="char-style-override-7">For Programme details please refer to the Recognition, Acknowledgements &amp; Commercial Support Section in the final programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-5"><span class="char-style-override-7"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 1: LESSONS FROM FRONTAL SINUS SURGERY CASES</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">W. Fokkens </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span><span class="char-style-override-5">145</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">U. Bockmühl </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">146</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">R. Harvey </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span><span class="char-style-override-6">147</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">S. Carrie </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-6">148</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">S. Sütay </span><span class="char-style-override-5">(Turkey)</span><span class="char-style-override-4"></span><span class="char-style-override-6">149</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">S. Haruna </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span><span class="char-style-override-6">150</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">N. Busaba </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-6">151</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">W. Bolger </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-6">152</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 2: HOW TO PERFORM TOP TIP SURGERY IN RHINOPLASTY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">P. Palma </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span><span class="char-style-override-5">153</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">R. Xavier </span><span class="char-style-override-5">(Portugal)</span><span class="char-style-override-4"></span><span class="char-style-override-6">154</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">P. Lekakis </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span><span class="char-style-override-6">155</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Sousa Vieira </span><span class="char-style-override-5">(Portugal)</span><span class="char-style-override-4"></span><span class="char-style-override-6">156</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Mesbahi </span><span class="char-style-override-5">(Iran)</span><span class="char-style-override-4"></span><span class="char-style-override-6">157</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">TBA</span><span class="char-style-override-5"> </span><span class="char-style-override-6"></span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 3: DIFFERENT APPROACHES TO SKULL BASE TUMOURS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">B. Woodworth </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-5">159</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">H. Gassner </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">160</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">C. Georgalas </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span><span class="char-style-override-6">161</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">H. Bergqvist </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-6">162</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">D. Lal </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-6">163</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">J.A. Eloy </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-6">164</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 4: WHAT TO EXPECT IN UPPER AIRWAY INFLAMMATION IN CHILDREN </span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">F. Baroody </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-5">165</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">E. Brozek-Madry </span><span class="char-style-override-5">(Poland)</span><span class="char-style-override-4"></span><span class="char-style-override-6">166</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">M. Westman </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-6">167</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">V. Kozlov </span><span class="char-style-override-5">(Russia)</span><span class="char-style-override-4"></span><span class="char-style-override-6">168</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">T. Yamada </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span><span class="char-style-override-6">169</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">L. Kalogjera </span><span class="char-style-override-5">(Croatia)</span><span class="char-style-override-4"></span><span class="char-style-override-6">170</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">N. Calder </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-6">171</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 5: THE NOSE IN THE ART AND CULTURE</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">L. Malm </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">172</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">E. Huizing </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span><span class="char-style-override-6">173</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">E. Stigare </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-6">174</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">J. Kumlien </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-6">175</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall F</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 6: STRATEGIES IN SURGICAL TRAINING OF FUTURE RHINOLOGISTS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">S. Carney </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span><span class="char-style-override-5">176</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">B. Coman </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span><span class="char-style-override-6">177</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">P. Stjärne </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-6">178</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">R. Sacks </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span><span class="char-style-override-6">179</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">N. Otori </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span><span class="char-style-override-6">180</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">H. Saleh </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-6">181</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">C. Sarafoleanu </span><span class="char-style-override-5">(Romania)</span><span class="char-style-override-4"></span><span class="char-style-override-6">182</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 7: THE NON-ALLERGIC NOSE – IT RUNS, IT BLOCKS …</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">M. Andersson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">183</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">L. Van Gerven </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span><span class="char-style-override-6">184</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">J. Hellgren </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-6">185</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">N. Keles </span><span class="char-style-override-5">(Turkey)</span><span class="char-style-override-4"></span><span class="char-style-override-6">186</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">J.S. Lacroix </span><span class="char-style-override-5">(Switzerland)</span><span class="char-style-override-4"></span><span class="char-style-override-6">187</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">S. Toppila-Salmi </span><span class="char-style-override-5">(Finland)</span><span class="char-style-override-4"></span><span class="char-style-override-6">188</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 7: MANAGEMENT OF CRS MEDICALLY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">T. Baudoin </span><span class="char-style-override-5">(Croatia)</span><span class="char-style-override-4"></span><span class="char-style-override-5">189</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:15	DEFINING THE HEALTHY POST-ESS SINUS CAVITY MICROBIOME FOR THERAPEUTIC SINUS MICROBIOME RE-ENGINEERING190</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">M.&nbsp;Alfelasi, L.&nbsp;Mfuna Endam, M.&nbsp;Surette, </span><span class="char-style-override-4">M.&nbsp;Desrosiers</span><span class="char-style-override-5"> (Canada)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:26	PRELIMINARY RESULTS OF A SURVEY TO IDENTIFY THE SOCIO-ECONOMIC COSTS OF CHRONIC RHINOSINUSITIS (CRS) TO PATIENTS AND THE NHS IN THE UNITED KINGDOM191</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">R.&nbsp;Smith, </span><span class="char-style-override-4">S.&nbsp;Erskine</span><span class="char-style-override-5">, C.&nbsp;Philpott (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:37	BENZALKONIUM CHLORIDE ENHANCES THE EXPRESSION OF HISTAMINE H1 RECEPTOR MRNA IN NASAL EPITHELIAL CELLS, WHICH IS REDUCED BY PRETREATMENT WITH MOMETASONE FUROATE192</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">Y.&nbsp;Kurono</span><span class="char-style-override-5">, M.&nbsp;Kawabata (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:48	EFFECTIVENESS OF ATORVASTATIN IN SUPPRESSING MUC5AC GENE EXPRESSION IN HUMAN AIRWAY EPITHELIAL CELLS193</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.J.&nbsp;Lee</span><span class="char-style-override-5">, K.S.&nbsp;Kim (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:59	CHARACTERISTICS OF MACROLIDE RESPONDERS IN PERSISTENT POST-SURGICAL RHINOSINUSITIS194</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">G.&nbsp;Oakley</span><span class="char-style-override-5">, J.&nbsp;Christensen, R.&nbsp;Sacks, R.&nbsp;Harvey (Australia)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:10	DEVELOPMENT OF AN ENGINEERED HONEY (SURGIHONEY™) AS A NOVEL ADJUNCTIVE BIOFILM-TARGETED THERAPY IN STAPHYLOCOCCUS AUREUS CHRONIC RHINOSINUSITIS195</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Salamat</span><span class="char-style-override-5">, R.&nbsp;Allan, S.&nbsp;Pender, R.&nbsp;Salib (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:21	DUPILUMAB IMPROVES PATIENT-REPORTED SYMPTOMS AND REDUCES DISEASE SEVERITY IN PATIENTS WITH NASAL POLYPOSIS: RESULTS FROM A PHASE 2A TRIAL196</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;Bachert</span><span class="char-style-override-5">, P.&nbsp;Hellings, J.&nbsp;Mullol, D.&nbsp;Hamilos, R.&nbsp;Naclerio, V.&nbsp;N.&nbsp;Joish, L.&nbsp;Mannent, R.&nbsp;Evans, A.&nbsp;Abbe, C.&nbsp;Amand, C.&nbsp;Taniou, D.&nbsp;Zhang, C.&nbsp;Fan, G.&nbsp;Pirozzi, N.&nbsp;Graham, V.&nbsp;Mastey, P.&nbsp;Mahajan, H.&nbsp;Staudinger, L.&nbsp;Eckert, A.&nbsp;Khan (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:32	DUPILUMAB REDUCES LOCAL TYPE 2 PROINFLAMMATORY BIOMARKERS IN PATIENTS WITH CHRONIC SINUSITIS AND NASAL POLYPOSIS197</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Jonstam</span><span class="char-style-override-5">, G.&nbsp;Holtappels, B.&nbsp;Swanson, L.&nbsp;Mannent, L.O.&nbsp;Cardell, N.&nbsp;Tian, Y.&nbsp;Wang, D.&nbsp;Zhang, C.&nbsp;Fan, J.&nbsp;Hamilton, A.&nbsp;Grabher, G.&nbsp;Pirozzi, C.&nbsp;Bachert (Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 8: OUTCOME ASSESSMENT IN CRS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">O. Fridman-Bengtsson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">198</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:15	EFFICACY OF BALLOON SINUPLASTY IN THE TREATMENT OF FRONTAL RHINOSINUSITIS: A PROSCPECTIVE STUDY199</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Bowles</span><span class="char-style-override-5">, S.&nbsp;Agrawal, M.&nbsp;Salam (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:25	SINONASAL OUTCOME TEST-23 (SNOT-23): PATIENT REPORTED OUTCOME MEASUREMENT IN ENDOSCOPIC SINUS SURGERY200</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D.&nbsp;Chandrasekharan</span><span class="char-style-override-5">, I.&nbsp;Beegun, L.&nbsp;Jennifer, J.&nbsp;Joseph, K.&nbsp;Whitcroft, P.&nbsp;Andrews, P.&nbsp;Randhawa (United Kingdom)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:35	A SYSTEMATIC REVIEW OF OUTCOMES IN CHRONIC RHINOSINUSITIS201</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Lakhani</span><span class="char-style-override-5">, A.&nbsp;Soni-Jaiwasl, C.&nbsp;Hopkins (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:45	USE OF EPOS 2012 STAGING SYSTEM TO ASSESS DISEASE CONTROL IN TREATED CRSWNP PATIENTS: ASSOCIATION WITH CLINICAL AND BIOLOGICAL MARKERS.202</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.M.&nbsp;López Chacón</span><span class="char-style-override-5">, I.&nbsp;Alobid, M.&nbsp;Martel, A.&nbsp;Cordero, C.&nbsp;Langdon, M.&nbsp;Fuentes-Prado, J.&nbsp;Roca-Ferrer, C.&nbsp;Picado, J.&nbsp;Mullol, L.&nbsp;Pujols (Spain)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:55	INVESTIGATION OF THE INCIDENCE OF EUSTACHIAN TUBE DYSFUNCTION IN PATIENTS WITH SINONASAL DISEASE203</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;Rennie</span><span class="char-style-override-5">, M.&nbsp;Gutierrez, V.&nbsp;Lund (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:05	THE IMPACT OF BITTER TASTE RECEPTORS ON CULTURABLE BACTERIA IN CHRONIC RHINOSINUSITIS204</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D.&nbsp;Rom</span><span class="char-style-override-5">, R.&nbsp;Harvey, J.&nbsp;Christensen, R.&nbsp;Sacks (Australia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:15	THE IMPORTANCE OF LOCAL EOSINOPHILIA IN THE SURGICAL OUTCOME OF CHRONIC RHINOSINUSITIS: A 3-YEAR PROSPECTIVE OBSERVATIONAL STUDY205</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Vlaminck</span><span class="char-style-override-5">, K.&nbsp;Speleman, P.&nbsp;Hellings, M.&nbsp;Jorissen, F.&nbsp;Acke, P.&nbsp;Van Cauwenberge, C.&nbsp;Bachert, P.&nbsp;Gevaert (Belgium)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:25	ANALYSIS OF SINONASAL AIRWAY MUCUS SECRETIONS HELPS IN PREDICTING OUTCOME AFTER ESS206</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Vlaminck</span><span class="char-style-override-5">, K.&nbsp;Speleman, H.&nbsp;Kawauchi, E.&nbsp;Prokopakis, J.C.&nbsp;Van Cutsem, F.&nbsp;Acke, P.&nbsp;Van Cauwenberge, M.&nbsp;Jorissen, P.&nbsp;Hellings, C.&nbsp;Bachert, P.&nbsp;Gevaert (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:35	PEAK NASAL INSPIRATORY FLOW RATES CORRELATE WITH QUALITY OF LIFE IN FUNCTIONAL ENDOSCOPIC SINUS SURGERY207</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Whitcroft</span><span class="char-style-override-5">, P.&nbsp;Andrews, P.&nbsp;Randhawa (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 9: MANAGEMENT OF SEVERE EPISTAXIS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">S. Dheyauldeen </span><span class="char-style-override-5">(Norway)</span><span class="char-style-override-4"></span><span class="char-style-override-5">208</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:15	PREDICTING RISK OF RECURRENT EPISTAXIS REQUIRING READMISSION:  LITERATURE REVIEW. DERIVATION AND VALIDATION OF RHINO-OOZE SCORE209</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Addison</span><span class="char-style-override-5">, R.&nbsp;Hettige, C.&nbsp;Paul, K.&nbsp;Rachel, A.&nbsp;Lamyman, P.&nbsp;Silva (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:26	AN OLD DRUG FOR A NEW APPLICATION: CARBAZOCHROME-SODIUM-SULFONATE IN HEREDITARY HEMORRHAGIC TELEANGIECTASIA210</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">R.&nbsp;Anzivino</span><span class="char-style-override-5">, G.C.&nbsp;Passali, E.&nbsp;De Corso, L.&nbsp;Di Gennaro, G.&nbsp;Bastanza, G.&nbsp;Costamagna, <br/>R.&nbsp;De Cristoforo, J.&nbsp;Galli, R.&nbsp;Landolfi, G.&nbsp;Paludetti, M.&nbsp;Pandolfini, M.E.&nbsp;Riccioni (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:37	SUPRASELECTIVE EMBOLIZATION IN INTRACTABLE EPISTAXIS: COMPLICATIONS AND OUTCOMES, LONG-TERM ANALYSIS.211</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">G.&nbsp;De Bonnecaze</span><span class="char-style-override-5">, Y.&nbsp;Gallois, F.&nbsp;Bonneville, S.&nbsp;Vergez, E.&nbsp;Serrano (France)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:48	MANAGEMENT OF SEVERE EPISTAXIS; A TWENTY SIX YEAR PERSONAL EXPERIENCE OF FINDING THE SOURCE212</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">B.&nbsp;Lang</span><span class="char-style-override-5">, J.&nbsp;Lang (Ireland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:59	NON-INVASIVE BLOOD TESTING IN EPISTAXIS213</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">R.&nbsp;Stadler, D.&nbsp;Holzmann, </span><span class="char-style-override-4">M.&nbsp;Soyka</span><span class="char-style-override-5"> (Switzerland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:10	LONG TERM RESULTS AND MORTALITY IN EPISTAXIS PATIENTS214</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">R.&nbsp;Kindler, R.&nbsp;Stadler, B.&nbsp;Landis, D.&nbsp;Holzmann, </span><span class="char-style-override-4">M.&nbsp;Soyka</span><span class="char-style-override-5"> (Switzerland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:21	EPISTAXIS IN NOVEL ANTICOAGULANT AGENT USE: DOES THE EVIDENCE REFLECT PATIENT EXPERIENCE?215</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Walker</span><span class="char-style-override-5">, D.&nbsp;Hassan, A.&nbsp;Takhar, J.&nbsp;Greenhill, P.&nbsp;Ames, B.&nbsp;Hunter (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:32	THE USE OF FLOSEAL IN THE TREATMENT OF ACUTE EPISTAXIS: A PROSPECTIVE CLINICAL TRIAL.216</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;Rennie</span><span class="char-style-override-5">, B.&nbsp;Van Beugen, B.&nbsp;Silver, H.&nbsp;Saleh (United Kingdom)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">15:45 - 16:15Exhibition</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">COFFEE BREAK, EXHIBITION AND POSTER VIEWING</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 1: SURGICAL MANAGEMENT OF SEPTAL PERFORATION</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">I. Alobid </span><span class="char-style-override-5">(Spain)</span><span class="char-style-override-4"></span><span class="char-style-override-6">217</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">P. Castelnuovo </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span><span class="char-style-override-6">218</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 2: TAKE US THROUGH THE DIFFICULT ANATOMY OF SINO-NASAL SURGERY!</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">W. Bolger </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-6">219</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 3: HHT</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">A. Kjeldsen </span><span class="char-style-override-5">(Denmark)</span><span class="char-style-override-4"></span><span class="char-style-override-6">220</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">S. Dheyauldeen </span><span class="char-style-override-5">(Norway)</span><span class="char-style-override-4"></span><span class="char-style-override-6">221</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">DEBATE: MINIMAL INVASIVE FESS VS FULLHOUSE FESS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair:</span><span class="char-style-override-4"> D. Kennedy</span><span class="char-style-override-5"> (USA)</span><span class="char-style-override-4"></span><span class="char-style-override-5">222</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	MINIMAL INVASIVE FESS223</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D. Simmen </span><span class="char-style-override-5">(Switzerland)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	FULLHOUSE FESS224</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Harvey </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	DISCUSSION	</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall F</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 4: JUVENILE ANGIOFIBROMA</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">M. Bernal Sprekelsen </span><span class="char-style-override-5">(Spain)</span><span class="char-style-override-4"></span><span class="char-style-override-6">225</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 5: ACADEMIC CAREER IN RHINOLOGY – WHAT FOR?</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">P. Hellings </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span><span class="char-style-override-6">226</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 10: PATHOPHYSIOLOGY OF CRS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">L. Cardell </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">227</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:15	THE NATURAL HiSTORY OF EOSINOPHILIC AND NON-EOSINOPHILIC CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP).228</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.&nbsp;De Corso</span><span class="char-style-override-5">, D.&nbsp;Lucidi, S.&nbsp;Baroni, M.&nbsp;Romanello, R.&nbsp;Cimorelli, C.&nbsp;Autilio, G.C.&nbsp;Passali, M.&nbsp;Battista, C.&nbsp;De vita, M.&nbsp;Rigante, G.&nbsp;Paludetti (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:24	DELAYED WOUND HEALING IN BASAL CELL RICH PRIMARY EPITHELIAL CRS CELL CULTuRES: EXPLORING THE ROLE OF BASAL CELLS IN THE PATHOPHYSIOLOGY OF CRS229</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">B.&nbsp;Ibrahim</span><span class="char-style-override-5">, L.&nbsp;Mfuna-Endam, M.&nbsp;Emilie, C.&nbsp;Bilodeau, E.&nbsp;Brochiero, M.&nbsp;Desrosiers (Canada)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:33	ROLE OF IL-10 ON PATHOGENESIS OF NASAL POLYP IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS230</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">Y.M.&nbsp;Kim, </span><span class="char-style-override-4">J.&nbsp;Xu</span><span class="char-style-override-5">, S.K.&nbsp;Park, K.S.&nbsp;Rha (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:42	RED WINE EXTRACT ACTIVATION OF BASOPHILS IN-VITRO, EVIDENCE FOR ETIOLOGY OF SYMPTOM EXACERBATION IN ASPIRIN EXACERBATED RESPIRATORY DISEASE?231</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Peters</span><span class="char-style-override-5">, J.&nbsp;Negri, J.&nbsp;Steinke, L.&nbsp;Borish, S.&nbsp;Payne (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:51	SINUS BACTERIOLOGY IN CYSTIC FIBROSIS AND PRIMARY CILIARY DYSKINESIA: A SYSTEMATIC REVIEW232</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Moeller</span><span class="char-style-override-5">, M.C.&nbsp;Alanin, C.&nbsp;Grønhøj Larsen, K.&nbsp;Aanaes, C.&nbsp;Von Buchwald (Denmark)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 11: NASAL SURGERY, TECHNIQUES</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">K. Steensland </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">233</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:15	EXTENDED AGGER NASI CELL APPROACH FOR SINUS INVERTED PAPILLOMA234</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">F.&nbsp;Chen, </span><span class="char-style-override-4">J.&nbsp;Shi</span><span class="char-style-override-5">, R.&nbsp;Xu, J.&nbsp;Guo, K.&nbsp;Zuo, H.&nbsp;Chen (China)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:24	3D ANATOMY OF PARANASAL SINUSES235</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Farneti</span><span class="char-style-override-5">, V.&nbsp;Sciarretta, O.&nbsp;Piccin, A.&nbsp;Riboldi, P.&nbsp;Tarchini, E.&nbsp;Pasquini (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:33	CLINICAL APPLICATION OF RESORBABLE POLYURETHANE NASAL PACKING IN ENDOSCOPIC SINUS SURGERY236</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">Z.&nbsp;Piski</span><span class="char-style-override-5">, I.&nbsp;Gerlinger, N.&nbsp;Nepp, P.&nbsp;Revesz, A.&nbsp;Burian, L.&nbsp;Lujber (Hungary)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:42	ENDOSCOPIC TREATMENT AND COMBINED EXTERNAL-TRANSNASAL ENDOSCOPIC APPROACH FOR THE TREATMENT OF INVERTED PAPILLOMA: A REPORT OF 145 CASES237</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">V.&nbsp;Sciarretta</span><span class="char-style-override-5">, P.&nbsp;Farneti, I.J.&nbsp;Fernandez, M.C.&nbsp;Cimatti, G.&nbsp;Macrì, E.&nbsp;Pasquini (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:51	TRANSNASAL ENDOSCOPIC MAXILLECTOMY: OPERATIVE NUANCES AND PROPOSAL OF A NEW CLASSIFICATION SYSTEM BASED ON 1378 CASES238</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Turri-Zanoni</span><span class="char-style-override-5">, P.&nbsp;Battaglia, A.&nbsp;Karligkiotis, D.&nbsp;Lepera, J.&nbsp;Zocchi, I.&nbsp;Dallan, M.&nbsp;Bignami, P.&nbsp;Castelnuovo (Italy)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 12: RHINOPLASTY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">B. Alinasab </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">239</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:15	BIPHASIC CALCIUM PHOSPHATE IMPLANT ASSESSMENT FOR COMPLEX SEPTORHINOPLASTIES: THE NASEPT STUDY240</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L.&nbsp;De Gabory</span><span class="char-style-override-5">, P.&nbsp;Boudard, J.P.&nbsp;Bessède, A.&nbsp;Bénard, S.&nbsp;Delmond, L.&nbsp;Bordenave (France)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:25	REVISION RHINOPLASTY: ARE THERE LESSONS TO LEARN?241</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Hettige</span><span class="char-style-override-5">, N.&nbsp;Bleach (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:35	IRRADIATED HOMOLOGOUS CADAVERIC COSTAL CARTILAGE VERSUS AUTOGENOUS COSTAL CARTILAGE FOR SEPTAL RECONSTRUCTION IN RHINOPLASTY: A COMPARATIVE MODELLED COST ANALYSIS242</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Hettige</span><span class="char-style-override-5">, R.&nbsp;Chawla, P.&nbsp;Martinez-Devesa, R.&nbsp;Almeyda (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:45	PATIENT SATISFACTION FOLLOWING INTRANASAL Z-PLASTY TO TREAT NASAL VALVE NARROWING243</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;Rennie</span><span class="char-style-override-5">, A.&nbsp;Hariri, H.&nbsp;Saleh (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 6: HOW TO CHOOSE YOUR PATIENTS IN RHINOPLASTY</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">P. Haraldsson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-6">244</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 7: HOW TO ASSESS THE NOSE</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">M. Holmstrom </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-6">245</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 8: HOW TO EVALUATE SMELL AND TASTE</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">T. Hummel </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">246</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">DEBATE: ENDOSCOPIC OR TRANSCRANIAL TECHNIQUE FOR TUMOURS OF THE SKULL BASE?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">M. Bernal Sprekelsen </span><span class="char-style-override-5">(Spain)</span><span class="char-style-override-4"></span><span class="char-style-override-5">247</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	ENDOSCOPIC TECHNIQUE248</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Carrau </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	TRANSCRANIAL TECHNIQUE249</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">T. Mathiesen </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	DISCUSSION	</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall F</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 9: WE WILL SHOW YOU HOW TO ANALYSE YOUR PREOPERATIVE CT SCAN</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">M.&nbsp;Lindén</span><span class="char-style-override-5"> (Sweden)</span><span class="char-style-override-6">250</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 10: A MODERN CONCEPT FOR CSF DIAGNOSIS AND MANAGEMENT</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">C. Meco </span><span class="char-style-override-5">(Turkey)</span><span class="char-style-override-4"></span><span class="char-style-override-6">251</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 13: SEPTAL AND TURBINATE SURGERY INCLUDING SEPTAL PERFORATIONS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">M. Andersson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">252</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:00	A FUNCTIONAL TOOL TO CHARACTERIZE NASAL VALVE COLLAPSE: THE FRIED TEST253</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Devars du mayne</span><span class="char-style-override-5">, M.&nbsp;Ramzi, E.&nbsp;Bequignon, F.&nbsp;Zerah-Lancner, A.&nbsp;Coste, B.&nbsp;Louis, J.F.&nbsp;Papon (France)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:09	INTRATURBINAL VERSUS EXTRATURBINAL MICRODEBRIDER-ASSISTED INFERIOR TURBINOPLASTY; PRELIMINARY RESULTS254</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;El Damaty</span><span class="char-style-override-5">, H.&nbsp;Badran, S.&nbsp;Amin, M.&nbsp;Salah (Oman)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:18	EMPTY NOSE SYNDROME AND HYPERVENTILATION SYNDROME255</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D.&nbsp;Mangin</span><span class="char-style-override-5">, E.&nbsp;Bequignon, F.&nbsp;Zerah, D.&nbsp;Isabey, B.&nbsp;Louis, J.F.&nbsp;Papon, A.&nbsp;Coste, L.&nbsp;Boyer, M.&nbsp;Devars Du Mayne (France)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:27	USAGE OF HYDRODYNAMIC RESISTANCE COEFFICIENT AS A DIAGNOSTIC PARAMETER IN THE SEPTOPLASTY DECISION-MAKING PROCESS256</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">A.&nbsp;Nechyporenko</span><span class="char-style-override-5">, O.&nbsp;Garyuk, V.&nbsp;Chmovzh (Ukraine)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:36	COMPARISON OF THERMIC EFFECTS OF COBLATION AND RADIOFREQUENCY WAVES IN A PORCINE TURBINATE MODEL257</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">M.&nbsp;Taurite, </span><span class="char-style-override-4">I.&nbsp;Daine-Loza</span><span class="char-style-override-5"> (Latvia)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 14: SEPTAL AND TURBINATE SURGERY INCLUDING SEPTAL PERFORATIONS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">I. Braverman </span><span class="char-style-override-5">(Israel)</span><span class="char-style-override-4"></span><span class="char-style-override-5">258</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:00	SEPTAL PERFORATION CLOSURE UTILIZING NASAL MUCOSAL FLAPS259</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">S.&nbsp;Bansberg</span><span class="char-style-override-5"> (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:11	EFFECTS OF NASAL WALL LATERALIZATION AND PYRIFORM TURBINOPLASTY ON NASAL CLIMATISATION260</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">F.&nbsp;Sommer</span><span class="char-style-override-5">, D.&nbsp;Simmen, T.&nbsp;Hoffmann, H.R.&nbsp;Briner, R.&nbsp;Kröger, J.&nbsp;Lindemann (Germany)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:22	ABOUT THE SWEDISH NASAL SEPTAL SURGERY REGISTER.261</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Ydreborg</span><span class="char-style-override-5">, C.&nbsp;Ahlström-Emanuelsson, C.&nbsp;Alexandersson, S.&nbsp;Blank, T.&nbsp;Norlander, H.&nbsp;Lundgaard Thulesius (Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:33	AN EXPLORATION OF THE PRACTISE OF SEPTOPLASTY IN THE UNITED KINGDOM: A QUALITATIVE STUDY262</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Carter</span><span class="char-style-override-5">, S.&nbsp;Erskine, I.&nbsp;Papachristou, C.&nbsp;Philpott, C.&nbsp;Hopkins (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 15: FACIAL PLASTIC SURGERY AND RHINOPLASTY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">C. East </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-5">263</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:00	NOVEL OUTCOME MEASUREMENT TOOL OF THE NASAL VALVE SURGERY: IMAGE ANALYSIS USING ENDOSCOPIC SYSTEM FOR SMARTPHONES264</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Surda</span><span class="char-style-override-5">, A.&nbsp;Walker, S.&nbsp;Little, A.&nbsp;Toma</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:09	A COMPARISON OF VOLUMETRIC DATA FROM ACOUSTIC RHINOMETRY AND 3T MRI IN THE CONGESTED AND DECONGESTED STATE265</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L.&nbsp;Ritchie</span><span class="char-style-override-5">, R.&nbsp;Cetto, C.&nbsp;Rennie, Q.&nbsp;Xiao, N.&nbsp;Tolley, D.&nbsp;Doorly (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:18	FUNCTIONAL RESPIRATORY IMAGING-AIDED VIRTUAL PREOPERATIVE PLANNING IN NASAL SURGERY: TOWARDS A PERSONALIZED APPROACH266</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.&nbsp;Ansari</span><span class="char-style-override-5">, W.&nbsp;Vos, C.&nbsp;Van Holsbeke, P.&nbsp;Lefebvre, A.L.&nbsp;Poirrier (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:27	RAPID RESORBABLE SUTURES IN CLOSING TRANSCOLUMELLAR INCISION IN OPEN RHINOPLASTY267</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">B.&nbsp;Alinasab</span><span class="char-style-override-5"> (Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:36	LONG TERM OUTCOMES OF NASAL RECONSTRUCTION IN RELAPSING ANCA ASSOCIATED VASCULITIS268</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">I.&nbsp;Kwame</span><span class="char-style-override-5">, C.&nbsp;Tornari, R.&nbsp;Kuchai, G.&nbsp;Sandhu, C.&nbsp;East, H.&nbsp;Saleh, P.&nbsp;Andrews, C.&nbsp;Pusey (United Kingdom)</span></p>
			</div>
		</div>
	</body>
</html>

								</div>
							</div>
						</div>
						<div class="row 200%">
							<div class="12u">

								<!-- Features -->
									<section class="box features">
										<h2 class="major"><span>A Major Heading</span></h2>
										<div>
											<div class="row">
												<div class="3u 12u(mobile)">

													<!-- Feature -->
														<section class="box feature">
															<a href="#" class="image featured"><img src="images/pic01.jpg" alt="" /></a>
															<h3><a href="#">A Subheading</a></h3>
															<p>
																Phasellus quam turpis, feugiat sit amet ornare in, a hendrerit in
																lectus dolore. Praesent semper mod quis eget sed etiam eu ante risus.
															</p>
														</section>

												</div>
												<div class="3u 12u(mobile)">

													<!-- Feature -->
														<section class="box feature">
															<a href="#" class="image featured"><img src="images/pic02.jpg" alt="" /></a>
															<h3><a href="#">Another Subheading</a></h3>
															<p>
																Phasellus quam turpis, feugiat sit amet ornare in, a hendrerit in
																lectus dolore. Praesent semper mod quis eget sed etiam eu ante risus.
															</p>
														</section>

												</div>
												<div class="3u 12u(mobile)">

													<!-- Feature -->
														<section class="box feature">
															<a href="#" class="image featured"><img src="images/pic03.jpg" alt="" /></a>
															<h3><a href="#">And Another</a></h3>
															<p>
																Phasellus quam turpis, feugiat sit amet ornare in, a hendrerit in
																lectus dolore. Praesent semper mod quis eget sed etiam eu ante risus.
															</p>
														</section>

												</div>
												<div class="3u 12u(mobile)">

													<!-- Feature -->
														<section class="box feature">
															<a href="#" class="image featured"><img src="images/pic04.jpg" alt="" /></a>
															<h3><a href="#">And One More</a></h3>
															<p>
																Phasellus quam turpis, feugiat sit amet ornare in, a hendrerit in
																lectus dolore. Praesent semper mod quis eget sed etiam eu ante risus.
															</p>
														</section>

												</div>
											</div>
											<div class="row">
												<div class="12u">
													<ul class="actions">
														<li><a href="#" class="button big">Do Something</a></li>
														<li><a href="#" class="button alt big">Think About It</a></li>
													</ul>
												</div>
											</div>
										</div>
									</section>

							</div>
						</div>
					</div>
				</div>

			<!-- Footer -->
				<footer id="footer" class="container">
					<div class="row 200%">
						<div class="12u">

							<!-- About -->
								<section>
									<h2 class="major"><span>What's this about?</span></h2>
									<p>
										This is <strong>TXT</strong>, yet another free responsive site template designed by
										<a href="http://twitter.com/ajlkn">AJ</a> for <a href="http://html5up.net">HTML5 UP</a>. It's released under the
										<a href="http://html5up.net/license/">Creative Commons Attribution</a> license so feel free to use it for
										whatever you're working on (personal or commercial), just be sure to give us credit for the design.
										That's basically it :)
									</p>
								</section>

						</div>
					</div>
					<div class="row 200%">
						<div class="12u">

							<!-- Contact -->
								<section>
									<h2 class="major"><span>Get in touch</span></h2>
									<ul class="contact">
										<li><a class="icon fa-facebook" href="#"><span class="label">Facebook</span></a></li>
										<li><a class="icon fa-twitter" href="#"><span class="label">Twitter</span></a></li>
										<li><a class="icon fa-instagram" href="#"><span class="label">Instagram</span></a></li>
										<li><a class="icon fa-dribbble" href="#"><span class="label">Dribbble</span></a></li>
										<li><a class="icon fa-google-plus" href="#"><span class="label">Google+</span></a></li>
									</ul>
								</section>

						</div>
					</div>

					<!-- Copyright -->
						<div id="copyright">
							<ul class="menu">
								<li>&copy; Untitled. All rights reserved</li><li>Design: <a href="http://html5up.net">HTML5 UP</a></li>
							</ul>
						</div>

				</footer>

		</div>

		<!-- Scripts -->
			<script src="assets/js/jquery.min.js"></script>
			<script src="assets/js/jquery.dropotron.min.js"></script>
			<script src="assets/js/skel.min.js"></script>
			<script src="assets/js/skel-viewport.min.js"></script>
			<script src="assets/js/util.js"></script>
			<!--[if lte IE 8]><script src="assets/js/ie/respond.min.js"></script><![endif]-->
			<script src="assets/js/main.js"></script>

	</body>
</html>